申请人:Bayer Aktiengesellschaft
公开号:US05304563A1
公开(公告)日:1994-04-19
The title compounds are prepared either by reacting the corresponding halogenomethylquinolines with substituted phenols, optionally subsequently alkylating these or hydrolysing esters to acids, or by reacting phenyl-substituted quinolinecarboxylic acid derivatives with sulphonamides. The new phenyl-substituted quinolines are utilizable as active substances in medicaments, in particular as lipoxygenase inhibitors.
这些标题化合物可以通过以下两种方法制备:将相应的卤代甲基喹啉与取代苯酚反应,随后可以选择性地烷基化或水解酯类化合物得到酸类化合物;或者将苯基取代的喹啉羧酸衍生物与磺胺酰胺反应。这些新的苯基取代喹啉可作为药物中的活性物质,特别是作为脂氧合酶抑制剂。